- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 21/08 - Monoclonal antibodies
Patent holdings for IPC class C12P 21/08
Total number of patents in this class: 4075
10-year publication summary
158
|
124
|
125
|
98
|
116
|
95
|
92
|
86
|
67
|
49
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Chugai Seiyaku Kabushiki Kaisha | 1368 |
135 |
Daiichi Sankyo Company, Limited | 1886 |
68 |
Genentech, Inc. | 4001 |
60 |
Amgen Inc. | 4105 |
54 |
Regeneron Pharmaceuticals, Inc. | 4335 |
54 |
F. Hoffmann-La Roche AG | 7947 |
51 |
Kyowa Hakko Kirin Co., Ltd. | 280 |
43 |
The Regents of the University of California | 20087 |
40 |
Toray Industries, Inc. | 6978 |
40 |
Kyowa Kirin Co., Ltd. | 367 |
38 |
Xencor, Inc. | 395 |
36 |
Abbvie Inc. | 1801 |
34 |
Astellas Pharma Inc. | 1085 |
33 |
MedImmune, LLC | 494 |
33 |
The University of Tokyo | 4208 |
33 |
Osaka University | 3388 |
32 |
Janssen Biotech, Inc. | 1559 |
29 |
Novartis AG | 10725 |
26 |
FUJIFILM Corporation | 29586 |
23 |
Zymeworks Inc. | 262 |
22 |
Other owners | 3191 |